LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis

Status Completed

Clinical Trial Summary

Radiation dermatitis is a common side-effect of radiation therapy in cancer patients who frequently can experience redness, pain, crusting, and even ulceration of the skin causing suffering and treatment interruption. A recent retrospective study by DeLand demonstrated that administering light emitting diode (LED) photomodulation after each radiation treatment for breast cancer decreased radiation dermatitis in a majority of patients. LED photomodulation is a process by which specific sequences of light are used to regulate or manipulate cell activity without causing heat or damage to the skin. Each LED treatment is painless and is completed in usually less than one minute. LED photomodulation may reduce the suffering associated with radiation treatments, improve cosmetic outcome in radiation fields, and eliminate breaks in radiation treatments which may be required because of severe ulcerating reactions.

This study will attempt to replicate the findings of Dr. DeLand's study by randomly assigning at least 40 breast cancer patients to either a treatment group or to a control group. The treatment group will receive LED photomodulation treatments before and after each radiation treatment with the Gentlewaves Select™ handheld high energy 590nm LED array using specific sequences of pulses used in other studies; the treatment group will also receive 7 additional treatments over 2 weeks after their radiation treatment course is completed. The control group will receive no LED treatment but will use the exact same skin care regimen as the treatment group. In addition to weekly evaluation and grading of skin reactions, subjects will be photographed under standardized conditions weekly and then photographs will be evaluated and graded by blinded dermatologists.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00573365
Study type	Interventional
Source	University of California, Irvine
Contact
Status	Completed
Phase	N/A
Start date	March 2007
Completion date	August 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04059809` - Photobiomodulation for Breast Cancer Radiodermatitis	Phase 2/Phase 3
Not yet recruiting	`NCT06040983` - Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing	N/A
Withdrawn	`NCT05505214` - Topical Steroids & Bacterial Decolonization for Radiation Dermatitis	Phase 2
Withdrawn	`NCT04593914` - A Novel Skin Barrier Protectant for Acute Radiodermatitis	N/A
Completed	`NCT05450848` - StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis	N/A
Active, not recruiting	`NCT05594498` - A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients	N/A
Recruiting	`NCT04110977` - A Reminder App to Reduce Radiation Dermatitis Rates in Patients With Head-and-Neck Cancer	N/A
Recruiting	`NCT06158347` - Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients With Localized Breast Cancer	N/A
Recruiting	`NCT05553392` - StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis	N/A
Active, not recruiting	`NCT04268056` - Characterization of Skin Microbiome Profile and it's Correlation to Radiation Dermatitis
Not yet recruiting	`NCT04888234` - Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis.	Phase 2
Terminated	`NCT01597921` - A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer	N/A
Completed	`NCT00481884` - Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients	Phase 3
Completed	`NCT03494205` - Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis	Phase 2
Completed	`NCT05810194` - Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
Completed	`NCT03941665` - Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients	N/A
Not yet recruiting	`NCT02051907` - Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis	Phase 2
Completed	`NCT02839473` - Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial	Phase 3
Completed	`NCT00876642` - Trial Comparing Best Supportive Care to Aloe Vera Gel	Phase 3
Completed	`NCT03910595` - Efficacy Study of Mepitel Film the Prophylaxis of Radiation-Induced Skin Reactions in Breast Cancer Patients	N/A